Zafgen Sets New 12-Month High at $21.81 (ZFGN)
Zafgen (NASDAQ:ZFGN)’s share price hit a new 52-week high during trading on Thursday , StockRatingsNetwork.com reports. The company traded as high as $21.81 and last traded at $21.29, with a volume of 65,901 shares traded. The stock had previously closed at $19.70.
A number of research firms have recently commented on ZFGN. Analysts at Canaccord Genuity initiated coverage on shares of Zafgen in a research note on Wednesday, August 13th. They set a “buy” rating and a $36.00 price target on the stock. Separately, analysts at JMP Securities initiated coverage on shares of Zafgen in a research note on Tuesday, July 29th. They set an “outperform” rating and a $31.00 price target on the stock. Finally, analysts at Leerink Swann initiated coverage on shares of Zafgen in a research note on Wednesday, July 23rd. They set an “outperform” rating and a $35.00 price target on the stock.
The stock’s 50-day moving average is $18.34 and its 200-day moving average is $18.70. The company’s market cap is $480.3 million.
Zafgen (NASDAQ:ZFGN) last posted its quarterly earnings results on Wednesday, August 13th. The company reported ($2.96) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.28) by $2.68. On average, analysts predict that Zafgen will post $-5.27 earnings per share for the current fiscal year.
Zafgen, Inc is a biopharmaceutical company. The Company is engaged in improving the health and well-being of patients affected by obesity.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.